Miguel Ángel Alcázar-Córcoles
Researcher in psychopathology and psychedelic studies (affiliation-based title not fully verified)
Data updated
Papers
Trials
Research Footprint
Miguel Ángel Alcázar-Córcoles appears in 6 tracked papers (2017–2023), most studied alongside Ayahuasca, Ibogaine and LSD, across Public Health, Prevention & Behaviour Change, Depressive Disorders and Anxiety Disorders.
Most-cited paper: Ayahuasca and Public Health: Health Status, Psychosocial Well-Being, Lifestyle, and Coping Strategies in a Large Sample of Ritual Ayahuasca Users (76 citations).
Frequent co-authors: Jamie Hallak, Rafael dos Santos and José Carlos Bouso.
Background & Research
Miguel Ángel Alcázar-Córcoles appears as a coauthor on several psychedelic science papers, including studies on ayahuasca, ibogaine, and lifetime psychedelic use during COVID-19. A university publication record identifies him as the last author on a paper from Universidad Autónoma de Madrid, indicating a leadership role in this research area.
Key Impact
He is a coauthor on multiple influential studies of ayahuasca, ibogaine, and psychedelics’ associations with mental health and well-being, including cross-cultural and longitudinal work.
Collaboration Network
7 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Miguel Ángel Alcázar-Córcoles is associated with.
Universidad Autonoma de Madrid
academicA leading public research university in Madrid, Spain, known for its strong programs in sciences, medicine, and the humanities. Founded in 1968, the Universidad Autónoma de Madrid (UAM) conducts internationally recognized research in neuroscience, pharmacology, and psychology, contributing to clinical studies on psychoactive substances and mental health.
View stakeholder →ICEERS
Non-ProfitICEERS is a Spain-based nonprofit focused on the globalization of Indigenous plant medicines, with work spanning education, research, legal support, and community services. Its website describes three connected areas of work: mitigating harms and consequences, co-creating collaborative pathways, and international monitoring and research. The organization serves people navigating psychoactive plant use, health professionals, and Indigenous and community partners across multiple countries. In psychedelic and drug policy work, ICEERS combines harm reduction, public education, and policy advocacy rather than operating as a patient-access organization. Its current public-facing services include free integration and crisis support through El Faro, a drug-interaction information service, educational resources, and legal defense support for people facing prosecution related to traditional medicines. ICEERS also reports work with Indigenous partners and claims its efforts have informed court rulings and public policy, making it relevant to researchers, clinicians, funders, policy groups, and community stakeholders seeking evidence, safety, and rights-based collaboration.
View stakeholder →